Development and external validation of a machine learning-based model to predict postoperative recurrence in patients with duodenal adenocarcinoma: a multicenter, retrospective cohort study

被引:0
作者
Liu, Xu [2 ]
Xiao, Qifeng [1 ]
Gu, Zongting [3 ]
Wu, Xin [4 ]
Yuan, Chunhui [5 ]
Tang, Xiaolong [6 ]
Meng, Fanbin [7 ]
Wang, Dong [8 ]
Lang, Ren [9 ]
Guo, Kaiqing [10 ]
Tian, Xiaodong [11 ]
Zhang, Yu [12 ]
Zhao, Enhong [13 ]
Wu, Zhenzhou [14 ]
Xu, Jingyong [15 ]
Xing, Ying [16 ]
Cao, Feng [17 ]
Wang, Chengfeng [1 ]
Zhang, Jianwei [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Pancreat & Gastr Surg,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[3] Hangzhou Med Coll, Affiliated Peoples Hosp, Zhejiang Prov Peoples Hosp,Gen Surg, Dept Hepatobiliary & Pancreat Surg & Minimally Inv, Hangzhou, Zhejiang, Peoples R China
[4] Peoples Liberat Army Gen Hosp, Med Ctr Chinese 1, Dept Gen Surg, Beijing, Peoples R China
[5] Peking Univ Third Hosp, Dept Gen Surg, Beijing, Peoples R China
[6] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Shandong, Peoples R China
[7] China Med Univ, Affiliated Hosp 1, Dept Pancreat & Biliary Surg, Shenyang, Liaoning, Peoples R China
[8] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China
[9] Capital Med Univ, Beijing ChaoYang Hosp, Dept Hepatobiliary & Pancreaticosplen Surg, Beijing, Peoples R China
[10] Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Shanxi Hosp,Canc Hosp,Hepatobiliary & Pancreatogas, Taiyuan 030013, Shanxi, Peoples R China
[11] Peking Univ First Hosp, Dept Gen Surg, Beijing, Peoples R China
[12] Shaanxi Prov Peoples Hosp, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China
[13] Chengde Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp, Chengde, Hebei, Peoples R China
[14] Hebei Med Univ, Hosp 2, Dept Oncol Surg, Shijiazhuang, Peoples R China
[15] Beijing Chaoyang Hosp, Dept Gen Surg, Beijing, Peoples R China
[16] Capital Med Univ Beijing, Tiantan Hosp, Gen Surg Dept, Beijing 100050, Peoples R China
[17] Capital Med Univ, Xuanwu Hosp, Dept Gen Surg, Beijing, Peoples R China
来源
BMC MEDICINE | 2025年 / 23卷 / 01期
关键词
Duodenal adenocarcinoma; Cancer recurrence; Surgery; Machine learning-based model; HEPATOCELLULAR-CARCINOMA; BLOOD-TRANSFUSION; SURVIVAL; CANCER; RESECTION; IMPACT; COMPLICATIONS; RECOVERY;
D O I
10.1186/s12916-025-03912-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDuodenal adenocarcinoma (DA) has a high recurrence rate, making the prediction of recurrence after surgery critically important.MethodsOur objective is to develop a machine learning-based model to predict the postoperative recurrence of DA. We conducted a multicenter, retrospective cohort study in China. 1830 patients with DA who underwent radical surgery between 2012 and 2023 were included. Wrapper methods were used to select optimal predictors by ten machine learning learners. Subsequently, these ten learners were utilized for model development. The model's performance was validated using three separate cohorts, and assessed by the concordance index (C-index), time-dependent calibration curve, time-dependent receiver operating characteristic curves, and decision curve analysis.ResultsAfter selecting predictors, ten feature subsets were identified. And ten feature subsets were combined with the ten machine learning learners in a permutation, resulting in the development of 100 predictive models, and the Penalized Regression + Accelerated Oblique Random Survival Forest model (PAM) exhibited the best predictive performance. The C-index for PAM was 0.882 (95% CI 0.860-0.886) in the training cohort, 0.747 (95% CI 0.683-0.798) in the validation cohort 1, 0.736 (95% CI 0.649-0.792) in the validation cohort 2, and 0.734 (95% CI 0.674-0.791) in the validation cohort 3. A publicly accessible web tool was developed for the PAM.ConclusionsThe PAM has the potential to identify postoperative recurrence in DA patients. This can assist clinicians in assessing the severity of the disease, facilitating patient follow-up, and aiding in the formulation of adjuvant treatment strategies.
引用
收藏
页数:14
相关论文
共 59 条
  • [1] Rethinking Resection and Transplant Candidacy for HCC: Should Tumor Biology Replace Size-Based Criteria?
    Acher, Alexandra W.
    Abbott, Daniel E.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (05) : 1309 - 1311
  • [2] Federated Survival Forests
    Archetti, Alberto
    Matteucci, Matteo
    [J]. 2023 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS, IJCNN, 2023,
  • [3] Asiff S K., 2023, International Journal of Research in Advanced Science and Engineering Technology, V2, P235, DOI DOI 10.22214/IJRASET.2023.54509
  • [4] The role of preoperative CEA in the management of colorectal cancer: A cohort study from two cancer centres
    Baqar, Ali Riaz
    Wilkins, Simon
    Staples, Margaret
    Lee, Chun Hin Angus
    Oliva, Karen
    McMurrick, Paul
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2019, 64 : 10 - 15
  • [5] Small Bowel Adenocarcinoma Version 1.2020
    Benson, Al B., III
    Venook, Alan P.
    Al-Hawary, Mahmoud M.
    Arain, Mustafa A.
    Chen, Yi-Jen
    Ciombor, Kristen K.
    Cohen, Stacey A.
    Cooper, Harry S.
    Deming, Dustin A.
    Garrido-Laguna, Ignacio
    Grem, Jean L.
    Hoffe, Sarah E.
    Hubbard, Joleen
    Hunt, Steven
    Kamel, Ahmed
    Kirilcuk, Natalie
    Krishnamurthi, Smitha
    Messersmith, Wells A.
    Meyerhardt, Jeffrey
    Miller, Eric D.
    Mulcahy, Mary F.
    Nurkin, Steven
    Overman, Michael J.
    Parikh, Aparna
    Patel, Hitendra
    Pedersen, Katrina S.
    Saltz, Leonard B.
    Schneider, Charles
    Shibata, David
    Skibber, John M.
    Sofocleous, Constantinos T.
    Stoffel, Elena M.
    Stotsky-Himelfarb, Eden
    Willett, Christopher G.
    Johnson-Chilla, Alyse
    Gregory, Kristina M.
    Gurski, Lisa A.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (09): : 1109 - 1133
  • [6] Delayed gastrointestinal recovery after abdominal operation - role of alvimopan
    Berger, Nicholas G.
    Ridolfi, Timothy J.
    Ludwig, Kirk A.
    [J]. CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2015, 8 : 231 - 234
  • [7] Complications after therapeutic trauma laparotomy
    Choi, KC
    Peek-Asa, C
    Lovell, M
    Torner, JC
    Zwerling, C
    Kealey, GP
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2005, 201 (04) : 546 - 553
  • [9] Does the Extent of Resection Impact Survival for Duodenal Adenocarcinoma? Analysis of 1,611 Cases
    Cloyd, Jordan M.
    Norton, Jeffrey A.
    Visser, Brendan C.
    Poultsides, George A.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (02) : 573 - 580
  • [10] Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.7326/M14-0697, 10.1136/bmj.g7594, 10.1016/j.jclinepi.2014.11.010, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.7326/M14-0698]